| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Serine/threonine-protein kinase Chk1 |
|---|
| Ligand | BDBM50359800 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_791990 (CHEMBL1930050) |
|---|
| IC50 | 3700±n/a nM |
|---|
| Citation |  Reader, JC; Matthews, TP; Klair, S; Cheung, KM; Scanlon, J; Proisy, N; Addison, G; Ellard, J; Piton, N; Taylor, S; Cherry, M; Fisher, M; Boxall, K; Burns, S; Walton, MI; Westwood, IM; Hayes, A; Eve, P; Valenti, M; de Haven Brandon, A; Box, G; van Montfort, RL; Williams, DH; Aherne, GW; Raynaud, FI; Eccles, SA; Garrett, MD; Collins, I Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing. J Med Chem54:8328-42 (2011) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Serine/threonine-protein kinase Chk1 |
|---|
| Name: | Serine/threonine-protein kinase Chk1 |
|---|
| Synonyms: | CHEK1 | CHK1 | CHK1 checkpoint homolog | CHK1_HUMAN | Checkpoint kinase-1 (CHK1) |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 54443.02 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | gi_166295192 |
|---|
| Residue: | 476 |
|---|
| Sequence: | MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK
MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY
LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK
RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA
LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDF
SPVNSASSEENVKYSSSQPEPRTGLSLWDTSPSYIDKLVQGISFSQPTCPDHMLLNSQLL
GTPGSSQNPWQRLVKRMTRFFTKLDADKSYQCLKETCEKLGYQWKKSCMNQVTISTTDRR
NNKLIFKVNLLEMDDKILVDFRLSKGDGLEFKRHFLKIKGKLIDIVSSQKIWLPAT
|
|
|
|---|
| BDBM50359800 |
|---|
| n/a |
|---|
| Name | BDBM50359800 |
|---|
| Synonyms: | CHEMBL1928678 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C16H16N6O |
|---|
| Mol. Mass. | 308.3378 |
|---|
| SMILES | NCC1CN(CCO1)c1ncnc2[nH]c3cc(ccc3c12)C#N |
|---|
| Structure | 
|
|---|
Search and Browse
